Loading…

Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study

Background: Patients with paediatric-onset multiple sclerosis (POMS) could be at an increased risk for cognitive impairment (CI), given the potential harmful effects of disease activity in neurodevelopment. However, there is scarce information on their long-term cognitive outcomes. Objective: To com...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis 2018-08, Vol.24 (9), p.1234-1242
Main Authors: Ruano, Luis, Branco, Mariana, Portaccio, Emilio, Goretti, Benedetta, Niccolai, Claudia, Patti, Francesco, Chisari, Clara, Gallo, Paolo, Grossi, Paola, Ghezzi, Angelo, Roscio, Marco, Mattioli, Flavia, Stampatori, Chiara, Simone, Marta, Viterbo, Rosa Gemma, Amato, Maria Pia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Patients with paediatric-onset multiple sclerosis (POMS) could be at an increased risk for cognitive impairment (CI), given the potential harmful effects of disease activity in neurodevelopment. However, there is scarce information on their long-term cognitive outcomes. Objective: To compare the prevalence and profile of CI between adults with a history of POMS and those with classic, adult-onset multiple sclerosis (AOMS). Methods: Cognitive performance was assessed through the Brief Repeatable Battery (BRB) and the Stroop Test in consecutive patients referred to six Italian MS centres. CI was defined as impairment in ⩾2 cognitive domains. Results: In all, 119 patients with POMS and 712 with AOMS were included in this analysis. The prevalence of CI was 48.0% in AOMS, 44.5% in POMS; with similar neuropsychological profile between the two groups. However, when adjusting for current age, we found a significantly increased risk for CI (odds ratio (OR) = 1.71; p = 0.02) and for impairment in information processing speed (OR = 1.86; p 
ISSN:1352-4585
1477-0970
DOI:10.1177/1352458517717341